Healthcare M&A update: H2 2023

Navigating uncertainty: Insights from the healthcare M&A landscape

The following report developed by Baker Tilly Capital, LLC provides an update on the healthcare mergers and acquisitions (M&A) market in the second half of 2023 (H2 2023). The report includes an overview of the market performance, M&A activity, transactions by segment and buyer, and U.S. middle market M&A activity. 

The second half of 2023 in healthcare M&A was a journey through uncertainty, marked by a blend of optimism and caution as the industry continued its recovery from the throes of the COVID-19 pandemic. 

Here are some key takeaways from the report:

• U.S. hospitals and health systems rebounded in H2 2023, with margins improving and a shift towards capital planning 
• BT Capital HC Index outperformed iShares U.S. Healthcare Providers Index but lagged behind tech-driven S&P 500 
• Physician services consolidation dominated via bolt-on deals by private equity platforms 
• Economic uncertainty, coupled with factors like borrowing costs and the impending presidential election, cast a shadow over the healthcare M&A landscape as it entered 2024 
• Healthcare services companies emerged as the most sought-after targets for buyers in H2 2023, comprising the majority of closed deals 

Get the pulse of the industry

For an in-depth look at M&A activity in the healthcare industry, download a copy of our healthcare M&A update: H2 2023. The report includes:

• Financial performance of specific healthcare sectors
• Major U.S. indexes performances
• Potential pricing regulation
• Notable transactions closed during H2

To view more on this topic or learn how Baker Tilly specialists can help, contact our team.

Baker Tilly Capital, LLC disclosure

Baker Tilly Capital, LLC privacy policy

Baker Tilly Capital, LLC social media disclaimer